Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4215315 | 0.83 | LMNA (0.34) | KMT2AMEN1 | |
| SCHEMBL712813 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL29659309 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL4212361 | 0.78 | — | — | |
| SCHEMBL17267904 | 0.76 | ALDH1A1 (0.33) | KMT2AMEN1GFER | |
| Hydrochloric Acid SCHEMBL1194185 | 0.72 | ALDH1A1 (0.34) | KMT2AMEN1 | |
| Pyridine SCHEMBL29860747 | 0.72 | PSMB5 (0.30) | — | |
| Pyridine SCHEMBL2130447 | 0.72 | PSMB5 (0.30) | — | |
| SCHEMBL16266909 | 0.66 | — | — | |
| SCHEMBL18011980 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507398-B2 | Catalysts for metathesis reactions | LANXESS DEUTSCHLAND GMBH (DE) | 2013-08-13 | — | — | US | disclosed |
| US-20090076226-A1 | CATALYSTS FOR METATHESIS REACTIONS | LANXESS DEUTSCHLAND GMBH (DE) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076226-A1 | CATALYSTS FOR METATHESIS REACTIONS | MCM4, MNS1, TERT | KMT2A 2670/4885MEN1 201/4885GFER 307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.